NIH-funded research P01 program project

Long-Term Follow-Up for Patients After Transplant and Cellular Immunotherapy

Official title: Core D: Long-Term Follow-Up

Funded at Fred Hutchinson Cancer Center · NIH-11420388 · Data updated 2026-11-12

A long-term data collection effort following people who had hematopoietic cell transplants or cellular immunotherapy to track health after treatment.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 28, 1997
Project endJuly 31, 2029
Funding year2026
Award (this year)$418,106
NIH project number5P01CA018029-50
Project IDNIH-11420388 on NIH RePORTER

Who could benefit from this research

Could help

Patients who have undergone hematopoietic cell transplantation or cellular immunotherapy at FHCC, UW, or SCH and require long-term follow-up data collection.

Less likely to help

Patients who are not in long-term follow-up cohorts or who do not consent to ongoing data collection may receive no direct benefit.

What this research studies

This program collects and manages long-term health data from patients who received hematopoietic cell transplants or cellular immunotherapy at FHCC, UW, or SCH. It tracks survival, late complications, and health outcomes for at least 15 years after treatment. The core supports ongoing projects by collecting data, obtaining additional biospecimens when needed, and ensuring data quality and accessibility for researchers. It also works to stay in contact with patients and physicians to obtain timely follow-up information. The goal is to enable researchers to understand long-term risks and outcomes to improve future patient care.

Why it matters

Potential benefit: If successful, patients could see improvements in long-term care, monitoring, and management of late effects after transplant or cellular therapy.

How similar studies have gone: Long-term follow-up registries and cohorts in transplant and cellular therapy have provided valuable insights into late effects and survival.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Lee, Stephanie J — Fred Hutchinson Cancer Center
  • Study coordinator: Lee, Stephanie J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.